SCHEDULE: Impax Asset Management Discloses Stake in Health Catalyst

Impax Asset Management Group plc and its subsidiary Impax Asset Management LLC have reported beneficial ownership of 5.4% of Health Catalyst, Inc. common stock as of June 30, 2026.

Summary

• Impax Asset Management Group plc, through its subsidiary Impax Asset Management LLC, has filed a Schedule 13G indicating beneficial ownership of 4,000,000 shares of Health Catalyst, Inc. common stock.
• This represents 5.4% of the class of securities.
• The filing entity, Impax Asset Management Group plc, is the parent company and 100% owner of Impax Asset Management LLC.
• Impax Asset Management LLC, as the investment manager, retains investment discretion and control over these shares.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating significant institutional interest without providing operational performance data.

Positives

• Impax Asset Management's significant stake suggests confidence in Health Catalyst's long-term prospects.
• The filing indicates a substantial investment of 4,000,000 shares, representing 5.4% of the class.

Risks

• The filing does not contain specific risk factors related to the investment itself, but general market risks for Health Catalyst's stock would apply.
• Potential for future changes in ownership or investment strategy by Impax Asset Management.

Future Outlook

The filing does not contain forward-looking statements or guidance from Health Catalyst. The information pertains to Impax Asset Management's ownership stake.

Management Comments

• Impax Asset Management Group plc (the filing entity) is the parent company and 100% owner of Impax Asset Management LLC.
• Impax Asset Management LLC, the Investment Manager, retains investment discretion and control over the shares.
• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that significant institutional ownership, as reported in this Schedule 13G filing by Impax Asset Management, often signals a belief in the company's growth trajectory within the healthcare technology sector.

Stakeholder Impact

• Shareholders may view the increased institutional ownership as a positive signal, potentially increasing demand for the stock.
• Management of Health Catalyst will be aware of the significant stake held by Impax Asset Management.

Next Steps

• Continued monitoring of Impax Asset Management's stake and any future filings.
• Observation of Health Catalyst's performance and strategic developments.

Key Dates

Keywords

Health Catalyst, Impax Asset Management, Schedule 13G, Beneficial Ownership, Investment, Healthcare Technology, SEC Filing, Common Stock